The outcomes indicated that eriodictyol’s protective effects against ALI involve the activation of proteins within the PI3K/AKT signal pathways, regulation of oxidative stress, attenuation of inflammation, and inhibition of hepatocyte apoptosis. This evidence concerns the gene AKT1 and acute respiratory distress syndrome.